Regarding the distinctive profiles of high-GS PCa patients, we identified WASIR1, KRTAP5-1, TLX1, KIF4A, and IQGAP3 as novel biomarkers associated with malignancy in PCa and built an inventive prognostic model to estimate the OS and PFS. The gene discussed is KIF4A; the disease is posterior cortical atrophy.